Helio Genomics appoints Gary Frazier as Chief Growth Officer

Feb. 7, 2024
Brings deep expertise in healthcare strategy, management and technology.

Helio Genomics has announced that Gary Frazier has been selected as Chief Growth Officer for the firm. Frazier brings extensive experience in several key aspects of healthcare to the position.

Frazier is the founder and CEO of two healthcare entities. Worksite Labs is an innovative diagnostic laboratory company. OM Healthcare is a digital front door software for direct-to-consumer healthcare. His experience also includes executive positions in several aspects of healthcare systems management.

He served as Vice President of Mergers and Acquisitions for Paladin Healthcare where he developed marketing and business strategies to identify markets, facilitate contacts and negotiate with prospective hospitals and health systems for potential mergers and acquisitions throughout the United States, as well as providing oversight and management for the delivery of all business development functions.

As Vice President of Strategy and Business Development with Dignity Health, Frazier was responsible for strategic planning, service line extension and growth for three hospitals in central California. That role also included leadership of communications and business development functions.

Frazier has 24 years of business development experience and 19 years of hospital and health system expertise.

Helio Genomics release on Newswise